Artificial intelligence tools for optimizing recruitment and retention in clinical trials: a scoping review protocol

Author:

Lu Xiaoran1ORCID,Chen Mingan2,Lu Zhuolin2,Shi Xiaoting3,Liang Lu2ORCID

Affiliation:

1. University of Liverpool

2. Central South University

3. Yale University

Abstract

Abstract Background In recent years, the influence of artificial intelligence technology on clinical trials has been steadily increasing. It has brought about significant improvements in the efficiency and cost reduction of clinical trials. The objective of this protocol is to conduct a comprehensive review that aims to systematically map, describe, and summarize the current utilization of artificial intelligence in recruitment and retention process of clinical trials. Additionally, it aims to identify the benefits and drawbacks, as well as the barriers and facilitators associated with the application of artificial intelligence in optimizing recruitment and retention in clinical trials. The findings of this review will provide valuable insights and recommendations for future development of artificial intelligence in the context of clinical trials . Methods The review of relevant literature will follow the methodological framework for scoping studies provided by the Joanna Briggs Institute. A comprehensive electronic search will be conducted using the search strategy developed by the authors. Leading medical and computer science databases such as PubMed, Embase, Scopus, IEEE Xplore and Web of Science Core Collection (including SCI-EXPANDED, SSCI, A&HCI, ESCI), will be searched. The search will encompass all original research, descriptive studies, randomized controlled trials, pilot studies, conference papers, comments and feasible or acceptable studies published in English, without any time limitations, that utilize artificial intelligence tools in the recruitment and retention process of clinical trials. The review team will carefully screen the identified studies and import them into a dedicated electronic library specifically created for this review. Data extraction will be performed using a data charting table, which will include publication details, study design, and specific outcomes/results. Discussion The objective of this scoping review is to provide a comprehensive overview of current status of artificial intelligence tools utilized in recruitment and retention process of clinical trials. By examining the existing literature, we aim to identify the barriers and facilitators that have influenced the application of these tools. Through our study, we will uncover gaps in the current knowledge, which can guide future research efforts. Additionally, our findings will offer recommendations to stakeholders regarding the use of artificial intelligence tools and may contribute to the advancement of their application in clinical trials. Systematic review registration: Open Science Framework https://osf.io/c9yhk/

Publisher

Research Square Platform LLC

Reference20 articles.

1. A study on the application and use of artificial intelligence to support drug development;Lamberti MJ;Clin Ther,2019

2. Copeland B. artificial intelligence. Encyclopedia Britannica. 2023. https://www.britannica.com/technology/artificial-intelligence. Accessed 12 May 2023.

3. The role of artificial intelligence in clinical decision support systems and a classification framework;Walczak S;Int J Comput Clin Pract,2018

4. Artificial intelligence in drug development: Present status and future prospects;Mak KK;Drug Discov Today,2019

5. From human intelligence to its implementation model-granular computing theory and method;Miao ZQ;J Intell Syst,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3